Bořek Lačňák

Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF

Sean D. Pokorney, Jonathan P. Piccini, Susanna R. Stevens et al. · Journal of the American Heart Association · 2016 · 196 citations · Full text

Free plasma metanephrines as a screening test for pheochromocytoma in low-risk patients

J. Václavík, David Stejskal, Bořek Lačňák et al. · Journal of Hypertension · 2007 · 69 citations

Aspirin resistance measured by cationic propyl gallate platelet aggregometry and recurrent cardiovascular events during 4 years of follow-up

David Stejskal, J. Václavík, Bořek Lačňák et al. · European Journal of Internal Medicine · 2006 · 38 citations

Thrombopoiesis, Thrombosis, Aspirin Resistance +9

Use of glycogen phosphorylase BB measurement with POCT in the diagnosis of acute coronary syndromes. A comparison with the ELISA method

David Stejskal, Bořek Lačňák, L Jedelský et al. · Biomedical Papers · 2007 · 17 citations · Full text

APPLICATION OF CATIONIC PROPYL GALLATE AS INDUCER OF THROMBOCYTE AGGREGATION FOR EVALUATION OF EFFECTIVENESS OF ANTIAGGREGATION THERAPY

David Stejskal, Jitka Prošková, Alena Petrželová et al. · Biomedical Papers · 2001 · 11 citations · Full text